Identification and characterization of citrulline-modified brain proteins by combining HCD and CID fragmentation
- PMID: 23828821
- PMCID: PMC4864592
- DOI: 10.1002/pmic.201300064
Identification and characterization of citrulline-modified brain proteins by combining HCD and CID fragmentation
Abstract
Citrullination is a protein PTM of arginine residues catalyzed by peptidylarginine deiminase. Protein citrullination has been detected in the CNS and associated with a number of neurological diseases. However, identifying citrullinated proteins from complex mixtures and pinpointing citrullinated residues have been limited. Using RP LC and high-resolution MS, this study determined in vitro citrullination sites of glial fibrillary acid protein (GFAP), neurogranin (NRGN/RC3), and myelin basic protein (MBP) and in vivo sites in brain protein extract. Human GFAP has five endogenous citrullination sites, R30, R36, R270, R406, and R416, and MBP has 14 in vivo citrullination sites. Human NRGN/RC3 was found citrullinated at residue R68. The sequence of citrullinated peptides and citrullination sites were confirmed from peptides identified in trypsin, Lys-C, and Glu-C digests. The relative ratio of citrullination was estimated by simultaneous identification of citrullinated and unmodified peptides from Alzheimer's and control brain samples. The site occupancy of citrullination at the residue R68 of NRGN ranged from 1.6 to 9.5%. Compared to CID, higher-energy collisional dissociation (HCD) mainly produced protein backbone fragmentation for citrullinated peptides. CID-triggered HCD fragmentation is an optimal approach for the identification of citrullinated peptides in complex protein digests.
Keywords: Biomedicine; Citrullination; GFAP; MBP; Mass spectrometry; NRGN.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Conflict of interest statement
The authors have declared no conflict of interest.
Figures



References
-
- Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, et al. Structural basis for Ca2+-induced activation of human PAD4. Nat Struct Mol Biol. 2004;11:777–783. - PubMed
-
- Harauz G, Musse AA. A tale of two citrullines - Structural and functional aspects of myelin basic protein deimination in health and disease. Neurochem Res. 2007;32:137–158. - PubMed
-
- Wegner N, Lundberg K, Kinloch A, Fisher B, Malmstrom V, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev. 2010;233:34–54. - PubMed
-
- Nicholas AP, Sambandam T, Echols JD, Tourtellotte WW. Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J Comp Neurol. 2004;473:128–136. - PubMed
-
- Ishigami A, Maruyama N. Importance of research on peptidylarginine deiminase and citrullinated proteins in age-related disease. Geriatr Gerontol Int. 2010;10:S53–S58. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous